Absolutely worthless. My dog is a doberman. They sent me, after a month and $149, a list of 3 commonly known conditions that Dobermans are prone to later in life noting his risk as "elevated." Really, no kidding. The department of the obvious has this important news bulletin for you: the sky is blue.
Claim your business profile now and gain access to all features and respond to customer reviews.
Embark is a canine genomics and biotechnology company based in Boston, Massachusetts.
